Breaking News Instant updates and real-time market news.

KEY

KeyCorp

$16.44

0.3 (1.86%)

, HBAN

Huntington Bancshares

$13.23

0.35 (2.72%)

04:55
08/30/19
08/30
04:55
08/30/19
04:55

Piper Jaffray to hold a trip

Ohio Regional Bank Trip travels throughout Ohio on August 29-30.

KEY

KeyCorp

$16.44

0.3 (1.86%)

HBAN

Huntington Bancshares

$13.23

0.35 (2.72%)

FITB

Fifth Third

$26.30

0.51 (1.98%)

  • 17

    Oct

  • 22

    Oct

  • 13

    Nov

KEY KeyCorp
$16.44

0.3 (1.86%)

04/04/19
JPMS
04/04/19
DOWNGRADE
Target $17
JPMS
Neutral
KeyCorp downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Steven Alexopoulos downgraded KeyCorp to Neutral from Overweight and lowered his price target for the shares to $17 from $18.
04/04/19
JPMS
04/04/19
NO CHANGE
JPMS
JPMorgan downgrades Comerica, Zions and KeyCorp, upgrades Signature Bank
In an attempt to reduce interest rate "sensitivity," JPMorgan analyst Steven Alexopoulos downgraded Comerica (CMA), Zions Bancorp (ZION) and KeyCorp (KEY) to Neutral from Overweight and upgraded Signature Bank (SBNY) to Overweight from Neutral. The analyst says his bearish call on the bank sector "remains fully intact" even though the stock are "technically now much cheaper" since his October 2018 call. The tailwinds that helped bottom line growth for banks over the past several years will "fully start transitioning into headwinds" during 2019, Alexopoulos tells investors in a research note. He suggests repositioning portfolios away from asset sensitive banks while simultaneously increasing exposure to liability sensitive banks.
06/21/19
BARD
06/21/19
UPGRADE
Target $19
BARD
Outperform
KeyCorp upgraded to Outperform from Neutral at Baird
Baird analyst David George upgraded KeyCorp to Outperform from Neutral and raised his price target for the shares to $19 from $18.
05/06/19
JEFF
05/06/19
NO CHANGE
Target $20
JEFF
Buy
KeyCorp price target raised to $20 from $18.50 at Jefferies
Jefferies analyst Ken Usdin raised his price target for KeyCorp to $20 from $18.50 after traveling with CEO Beth Mooney and CFO Don Kimble. The analyst finds the stock's valuation attractive at nine times 2020 earnings estimates. He looks for a "stronger" Q2 and better estimate stability, especially given the company's $1B share buyback plan. Usdin keeps a Buy rating on KeyCorp.
HBAN Huntington Bancshares
$13.23

0.35 (2.72%)

07/08/19
BMOC
07/08/19
DOWNGRADE
Target $14
BMOC
Underperform
Huntington Bancshares downgraded to Underperform at BMO Capital
BMO Capital analyst Lana Chan downgraded Huntington Bancshares (HBAN) to Underperform from Market Perform with an unchanged price target of $14. The analyst sees only 5% total return in shares compared to an average 14% total return potential for other regional banks. Chan lowered her estimates for Huntington to account for a lower rate environment and higher costs for hedging. Further, the company has less support than peers from stock buybacks, the analyst tells investors. She prefers shares of Outperform-rated Regions Financial (RF) over Huntington Bancshares.
05/31/19
ARGS
05/31/19
INITIATION
ARGS
Hold
Huntington Bancshares initiated with a Hold at Argus
Argus analyst Kevin Heal started Huntington Bancshares with a Hold rating after its Q1 results, saying the company saw a 10% increase in earnings and also noting its "strong balance sheet and a commitment to dividend hikes and stock buybacks." The analyst notes however that the bank could see pressure from rising technology costs and that its net interest margins may turn flat given the pause in interest rate tightening by the Fed. Heal adds that the 9.8-times forward earnings valuation on the stock is below the average for regional banking peers but reflects Huntington's prospects for slower near term growth in its core geography.
04/04/19
GSCO
04/04/19
DOWNGRADE
Target $84
GSCO
Neutral
Goldman downgrades Comerica to Neutral from Buy as rate hikes wane
Goldman Sachs analyst Ryan Nash downgraded Comerica (CMA) to Neutral from Buy and lowered his price target for the shares to $84 from $89. While loan growth has begun to improve from the lows, a lack of additional interest rate hikes, along with more exposure to consumer deposits continuing to re-price higher, likely means that the company's margins will begin to compress beyond Q1, Nash tells investors in a research note. He believes this will "pressure" consensus estimates. In the Regional Banks space, the analyst is most upbeat on Signature Bank (SBNY), Citizens Financial (CFG) and Cadence Bancorp (CADE) into Q1. He's less optimistic on First Horizon (FHN) and Huntington Bancshares (HBAN).
07/12/19
MACQ
07/12/19
DOWNGRADE
MACQ
Underperform
Huntington Bancshares downgraded to Underperform from Neutral at Macquarie
Macquarie analyst David Konrad downgraded Huntington Bancshares to Underperform from Neutral with a $14 saying he expects greater-than-peer NIM pressure due to the inverted yield curve and lower purchase accounting. Konrad expects negative estimate revisions to be driven by NIM pressure and said shares appear expensive.
FITB Fifth Third
$26.30

0.51 (1.98%)

04/25/19
BMOC
04/25/19
NO CHANGE
Target $33
BMOC
Market Perform
Fifth Third price target raised to $33 from $30 at BMO Capital
BMO Capital analyst Lana Chan raised her price target on Fifth Third to $33 after its "revenue-driven" Q1 earnings beat and better than expected balance sheet growth. The analyst is keeping her Market Perform rating on the stock, saying its discount valuation relative to its regional bank peers is warranted by the "uncertainty" around the company's ability to achieve its 2020 targets.
04/17/19
JEFF
04/17/19
DOWNGRADE
Target $84
JEFF
Hold
Comerica downgraded to Hold from Buy at Jefferies
Jefferies analyst Kenneth Usdin downgraded Comerica (CMA) to Hold from Buy with an unchanged price target of $84. Following negative earnings revisions post the company's Q1 results, the analyst does not see enough upside to warrant a Buy rating. Comerica's net interest income outlook is "proving even more challenging," with another deposit cost increase in March weighing most on forward estimates, Usdin tells investors in a research note. He prefers putting new money to work into Fifth Third Bancorp (FITB) for exposure to the regional banks.
07/12/19
SBSH
07/12/19
DOWNGRADE
SBSH
Neutral
Fifth Third downgraded to Neutral from Buy at Citi
Citi analyst Keith Horowitz downgraded Fifth Third Bancorp to Neutral from Buy.
07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.

TODAY'S FREE FLY STORIES

KMI

Kinder Morgan

$21.03

0.1 (0.48%)

16:06
01/22/20
01/22
16:06
01/22/20
16:06
Earnings
Kinder Morgan reports Q4 adjusted EPS 26c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

OPXS

Optex Systems

$0.00

(0.00%)

16:06
01/22/20
01/22
16:06
01/22/20
16:06
Hot Stocks
Optex Systems awarded $1.1M order for optical assemblies »

Optex Systems Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

FUL

H.B. Fuller

$49.24

0.16 (0.33%)

16:06
01/22/20
01/22
16:06
01/22/20
16:06
Earnings
H.B. Fuller reports Q4 adjusted EPS 88c, consensus 92c »

Reports Q4 revenue $739M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PTC

PTC

$79.95

1.02 (1.29%)

16:05
01/22/20
01/22
16:05
01/22/20
16:05
Earnings
PTC sees FY20 EPS $2.15-$2.65, consensus $2.17 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 12

    Feb

TCBI

Texas Capital

$53.41

-0.45 (-0.84%)

16:05
01/22/20
01/22
16:05
01/22/20
16:05
Earnings
Texas Capital reports Q4 EPS $1.42, consensus $1.51 »

Q4 net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

16:05
01/22/20
01/22
16:05
01/22/20
16:05
General news
Treasury Market Summary »

Treasury Market Summary:…

TXN

Texas Instruments

$133.37

2.52 (1.93%)

16:04
01/22/20
01/22
16:04
01/22/20
16:04
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

PTC

PTC

$79.89

0.96 (1.22%)

16:04
01/22/20
01/22
16:04
01/22/20
16:04
Earnings
PTC reports Q1 adjusted EPS 57c, consensus 44c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 12

    Feb

TXN

Texas Instruments

$133.50

2.65 (2.03%)

16:03
01/22/20
01/22
16:03
01/22/20
16:03
Hot Stocks
Texas Instruments CEO says 'most markets showed signs of stabilizing' »

Rich Templeton, TI's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

MSON

Misonix

$20.15

0.15 (0.75%)

16:03
01/22/20
01/22
16:03
01/22/20
16:03
Syndicate
Misonix announces offering of common stock »

Misonix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$133.37

2.515 (1.92%)

16:02
01/22/20
01/22
16:02
01/22/20
16:02
Earnings
Texas Instruments sees Q1 EPS 96c-$1.14, consensus $1.03 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

XENE

Xenon Pharmaceuticals

$16.80

0.11 (0.66%)

16:02
01/22/20
01/22
16:02
01/22/20
16:02
Syndicate
Xenon Pharmaceuticals announces offering of common shares »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$4.67

-0.04 (-0.85%)

16:02
01/22/20
01/22
16:02
01/22/20
16:02
Syndicate
ImmunoGen files to sell common stock, no amount given »

Jefferies, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVCY

Central Valley Community

$19.84

-0.66 (-3.22%)

16:01
01/22/20
01/22
16:01
01/22/20
16:01
Earnings
Central Valley Community reports Q4 EPS 34c, consensus 34c »

"We are pleased with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$133.22

2.37 (1.81%)

16:01
01/22/20
01/22
16:01
01/22/20
16:01
Earnings
Texas Instruments reports Q4 EPS $1.12, consensus $1.02 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

AVYA

Avaya

$13.96

0.11 (0.79%)

16:00
01/22/20
01/22
16:00
01/22/20
16:00
Hot Stocks
Avaya names Simon Harrison as Chief Marketing Officer »

Avaya announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, DARE

Dare Bioscience

$1.74

0.075 (4.52%)

15:55
01/22/20
01/22
15:55
01/22/20
15:55
Conference/Events
Dare Bioscience to hold a conference call »

Conference call to…

BAYRY

Bayer

$0.00

(0.00%)

DARE

Dare Bioscience

$1.74

0.075 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 13

    Feb

VTNR

Vertex Energy

$1.86

0.09 (5.10%)

15:55
01/22/20
01/22
15:55
01/22/20
15:55
Conference/Events
Vertex Energy to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 02

    Apr

NTIP

Network-1 Technologies

$2.36

0.07 (3.06%)

15:54
01/22/20
01/22
15:54
01/22/20
15:54
Hot Stocks
Network-1 Technologies receives new patent from U.S. Patent Office »

Network-1 Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$8.79

-0.25 (-2.77%)

15:45
01/22/20
01/22
15:45
01/22/20
15:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

TER

Teradyne

$73.08

1.55 (2.17%)

15:34
01/22/20
01/22
15:34
01/22/20
15:34
Options
Teradyne options imply 10.2% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CTXS

Citrix

$119.45

1.66 (1.41%)

15:19
01/22/20
01/22
15:19
01/22/20
15:19
Options
Citrix options imply 7.2% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
01/22/20
01/22
15:17
01/22/20
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
01/22/20
01/22
15:16
01/22/20
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$72.03

-7.66 (-9.61%)

15:10
01/22/20
01/22
15:10
01/22/20
15:10
Recommendations
Blueprint Medicines analyst commentary  »

Amendment to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.